Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ThermoGenesis cuts loss, rises $4.8 million:

This article was originally published in Clinica

Executive Summary

Californian biomaterials company ThermoGenesis has raised $4.8m in private financing through the sale of 3.1 million shares to institutional investors. The designer, manufacturer and producer of devices used in processing therapeutically valuable blood components, has also issued three-year warrants to acquire an additional 11,976 shares. CEO Philip Coelho says the finance will be used for working capital and to bolster the company's bid for self-sufficiency. The Rancho Cordova's 2002 final year results showed an 18% decrease in net loss to $5m on sales up 65% at $9.5m.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061572

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel